Table 2.
Prospective association of baseline CRP with fatigue at follow-up (N=2921)
Adjustment* | β | P | R2 | ΔR2 due to CRP | % ΔR2 due to CRP |
---|---|---|---|---|---|
Unadjusted model | 0.126 | <0.001 | 0.016 | 0.016 | 100% |
Model 1: Sociodemographic variables | 0.113 | <0.001 | 0.038 | 0.012 | 32.1% |
Model 2: Model 1 + Biomedical factors | 0.060 | 0.006 | 0.047 | 0.002 | 5.3% |
Model 3: Model 2 + Fatigue-related symptoms | 0.055 | 0.008 | 0.137 | 0.002 | 1.5% |
Model 4: Model 3 + Health-related behaviors | 0.044§ | 0.033 | 0.153 | 0.001 | 0.9% |
β = standardized regression coefficient expressing the change in standardized fatigue score per one standard deviation in CRP concentration; CRP = C-reactive protein; R2 = R-square of the model; ΔR2 = change in R-square; % ΔR2= percentage change in R-square
Sociodemographic variables include age, sex, ethnicity, and education. Biomedical factors include body-mass index, systolic blood pressure, and regular aspirin use. Fatigue-related symptoms include depressive symptoms, sleep quality, and pain. Health-related behaviors include smoking, alcohol consumption, and physical activity.
No effect modification was observed for age (P = 0.259), sex (P = 0.542), ethnicity (P = 0.779), or education (P = 0.987).